Velsera, Solaris collaborate to expand access to genetic testing for cancer patients
Under the partnership, affiliates of Solaris Health will use Velsera’s Clinical Genomics Workspace platform to provide inherited cancer…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Nov 23
Under the partnership, affiliates of Solaris Health will use Velsera’s Clinical Genomics Workspace platform to provide inherited cancer…
06 Nov 23
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare
03 Nov 23
The Alinity m high-risk (HR) HPV assay is approved for detecting HPV through routine cervical cancer screening using…
03 Nov 23
The partnership will combine QIAGEN’s QIAseq panels, CLC LightSpeed, and QCI Interpret software to support customers using Element’s…
03 Nov 23
As per patient-reported outcomes, the study revealed a 99% enhancement in AFib control and a 93.1% improvement in…
03 Nov 23
Powerful and comprehensive health monitoring platform now offers FDA-cleared biomarkers for pulse and respiratory rate
02 Nov 23
Under the deal, Inari will pay $250m in cash upon closing and LimFlow will be able to receive…
02 Nov 23
Under the partnership, Embolx plans to use Girlow's established distribution channels and network to make the Sniper Balloon…
02 Nov 23
The gloves identify the tremors in patients' hands and automatically apply electric current to stimulate the hand muscles…
02 Nov 23
Intellectual property rights secured in one of the largest target markets for CollPlant's potential products